• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎:一种由先天性免疫缺陷引起的疾病?

Atopic dermatitis: a disease caused by innate immune defects?

作者信息

De Benedetto Anna, Agnihothri Ritesh, McGirt Laura Y, Bankova Lora G, Beck Lisa A

机构信息

Department of Dermatology, University of Rochester Medical Center, Rochester, New York 14642, USA.

出版信息

J Invest Dermatol. 2009 Jan;129(1):14-30. doi: 10.1038/jid.2008.259.

DOI:10.1038/jid.2008.259
PMID:19078985
Abstract

Atopic dermatitis (AD) is a common chronic inflammatory skin disease that has increased in prevalence over the last half century. A growing body of evidence suggests that there are a variety of defects in the innate immune system that collectively affect the development and severity of AD. The reduction in antimicrobial peptides, diminished recruitment of innate immune cells (PMNs, pDC, and NK cells) to the skin, epithelial barrier disruption, and TLR2 defects are just some of the credible explanations for AD patients' susceptibility to pathogens such as Staphylococcus aureus, herpes simplex virus, and vaccinia virus. Although the focus for several years has been to identify defects in the innate immune system that might explain AD patients' susceptibility to cutaneous pathogens, it has become clear that some innate immune defects might promote inflammation and thereby aggravate or even induce the development of AD. Here we review the innate immune system, and highlight many of the potential innate networks that may be important in AD patients susceptible to cutaneous pathogens.

摘要

特应性皮炎(AD)是一种常见的慢性炎症性皮肤病,在过去半个世纪中患病率有所上升。越来越多的证据表明,先天性免疫系统存在多种缺陷,这些缺陷共同影响着AD的发生发展和严重程度。抗菌肽减少、先天性免疫细胞(中性粒细胞、浆细胞样树突状细胞和自然杀伤细胞)向皮肤的募集减少、上皮屏障破坏以及Toll样受体2(TLR2)缺陷,只是AD患者易感染金黄色葡萄球菌、单纯疱疹病毒和痘苗病毒等病原体的部分可信解释。尽管多年来的重点一直是确定先天性免疫系统中可能解释AD患者易患皮肤病原体的缺陷,但很明显,一些先天性免疫缺陷可能会促进炎症,从而加重甚至诱发AD的发生。在此,我们综述先天性免疫系统,并强调许多可能在易患皮肤病原体的AD患者中起重要作用的潜在先天性网络。

相似文献

1
Atopic dermatitis: a disease caused by innate immune defects?特应性皮炎:一种由先天性免疫缺陷引起的疾病?
J Invest Dermatol. 2009 Jan;129(1):14-30. doi: 10.1038/jid.2008.259.
2
Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.Toll 样受体 2 配体通过 IL-4 介导的 IL-10 抑制促进慢性特应性皮炎。
J Allergy Clin Immunol. 2014 Jul;134(1):92-9. doi: 10.1016/j.jaci.2014.02.017. Epub 2014 Apr 1.
3
Innate immune defects in atopic dermatitis.特应性皮炎中的先天性免疫缺陷。
J Allergy Clin Immunol. 2006 Jul;118(1):202-8. doi: 10.1016/j.jaci.2006.04.033. Epub 2006 Jun 6.
4
The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.天然免疫信号在特应性皮炎发病机制中的作用及对治疗的影响。
Semin Immunopathol. 2016 Jan;38(1):29-43. doi: 10.1007/s00281-015-0544-y. Epub 2015 Nov 16.
5
Modifications of the innate immune system in atopic dermatitis.特应性皮炎中固有免疫系统的改变。
J Innate Immun. 2011;3(2):131-41. doi: 10.1159/000323963. Epub 2011 Jan 21.
6
Insight into newly discovered innate immune modulation in atopic dermatitis.深入了解特应性皮炎中最新发现的固有免疫调节。
Exp Dermatol. 2013 Jan;22(1):6-9. doi: 10.1111/exd.12034. Epub 2012 Oct 23.
7
New insights in the pathogenesis of atopic dermatitis.特应性皮炎发病机制的新见解。
Pediatr Res. 2014 Jan;75(1-2):171-5. doi: 10.1038/pr.2013.196. Epub 2013 Nov 5.
8
Innate immunity in atopic dermatitis.特应性皮炎中的先天性免疫。
Curr Probl Dermatol. 2011;41:104-111. doi: 10.1159/000323304. Epub 2011 May 12.
9
Dissecting the role of infections in atopic dermatitis.剖析感染在特应性皮炎中的作用。
Acta Derm Venereol. 2006;86(2):99-109. doi: 10.2340/00015555-0047.
10
How the innate immune system trains immunity: lessons from studying atopic dermatitis and cutaneous bacteria.先天免疫系统如何训练免疫力:从研究特应性皮炎和皮肤细菌中获得的启示
J Dtsch Dermatol Ges. 2016 Feb;14(2):153-6. doi: 10.1111/ddg.12843. Epub 2016 Jan 20.

引用本文的文献

1
Inflammasome pathways in atopic dermatitis: insights into inflammatory mechanisms and therapeutic targets.特应性皮炎中的炎性小体通路:对炎症机制和治疗靶点的见解
An Bras Dermatol. 2025 Jun 23;100(4):501136. doi: 10.1016/j.abd.2025.501136.
2
Bioinformatics‑Based Analysis Reveals Diagnostic Biomarkers and Immune Landscape in Atopic Dermatitis.基于生物信息学的分析揭示了特应性皮炎的诊断生物标志物和免疫格局。
Clin Cosmet Investig Dermatol. 2025 May 1;18:1071-1085. doi: 10.2147/CCID.S510044. eCollection 2025.
3
The Western Diet and Atopic Dermatitis: The Potential Role of Nutrients, Contaminants, and Additives in Dysbiosis and Epithelial Barrier Dysfunction.
西方饮食与特应性皮炎:营养素、污染物和添加剂在肠道菌群失调及上皮屏障功能障碍中的潜在作用
Antioxidants (Basel). 2025 Mar 25;14(4):386. doi: 10.3390/antiox14040386.
4
The primary mechanisms underlying atopic dermatitis.特应性皮炎的主要潜在机制。
Tunis Med. 2025 Jan 5;103(1):65-72. doi: 10.62438/tunismed.v103i1.5220.
5
The role of neutrophils in allergic disease.中性粒细胞在过敏性疾病中的作用。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae126.
6
Updated insights into the molecular pathogenesis of canine atopic dermatitis.犬特应性皮炎分子发病机制的最新见解
Vet Dermatol. 2025 Aug;36(4):375-384. doi: 10.1111/vde.13300. Epub 2024 Sep 25.
7
Anti-Atopic Effect of and on Atopic Dermatitis-like Lesions in Mice by Experimental Verification and Compound-Target Prediction.通过实验验证和化合物靶点预测研究[具体物质]对小鼠特应性皮炎样皮损的抗特应性作用
Pharmaceuticals (Basel). 2024 Feb 20;17(3):269. doi: 10.3390/ph17030269.
8
Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand.基于麦卢卡油的 ECMT-154 与载体对照治疗湿疹的局部治疗:新西兰社区药房中一项随机对照试验的研究方案。
BMC Complement Med Ther. 2024 Jan 29;24(1):61. doi: 10.1186/s12906-024-04358-9.
9
Advancements in Allergen Immunotherapy for the Treatment of Atopic Dermatitis.用于治疗特应性皮炎的变应原免疫疗法的进展
Int J Mol Sci. 2024 Jan 21;25(2):1316. doi: 10.3390/ijms25021316.
10
Antioxidant, Antibacterial Properties of Novel Peptide CP by Enzymatic Hydrolysis of By-Products and Its Efficacy on Atopic Dermatitis.新型肽 CP 通过酶解副产物的抗氧化、抗菌特性及其对特应性皮炎的疗效。
Mar Drugs. 2024 Jan 12;22(1):44. doi: 10.3390/md22010044.